Form 4: Allstate EVP DeBiase Reports Equity Awards
Insider Transaction Report
Allstate's EVP, CLO, and General Counsel, Christine M. DeBiase, reported new equity awards and RSU conversions.
Summary
- Christine M. DeBiase, EVP, CLO, and General Counsel of The Allstate Corporation, reported several equity transactions.
- On February 21, 2026, 905 Restricted Stock Units (RSUs) converted into an equal number of common shares.
- Concurrently, 459 common shares were disposed of at a price of $206.37 per share, likely for tax withholding purposes related to the RSU conversion.
- On February 19, 2026, DeBiase was granted 8,596 employee stock options with an exercise price of $203.22, vesting in three equal increments on February 19, 2027, 2028, and 2029, and expiring on February 19, 2036.
- Also on February 19, 2026, DeBiase received an award of 2,097 Restricted Stock Units, which will convert into common stock in three equal increments on February 19, 2027, 2028, and 2029.
- A remaining 905 previously awarded RSUs are scheduled to convert into common shares on February 21, 2027.
- Following these transactions, DeBiase beneficially owns 11,707.904 shares of common stock directly.
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a moderately positive signal, reflecting standard executive compensation practices that align management incentives with long-term company performance, without indicating any immediate operational or financial changes.
Positives
- Grant of 8,596 employee stock options indicates continued incentive for management performance.
- Award of 2,097 Restricted Stock Units aligns management's interests with shareholder value creation.
- Conversion of 905 RSUs into common stock increases direct ownership in the company.
Negatives
- Disposition of 459 common shares, likely for tax purposes, reduces direct share ownership, though this is a standard practice for equity awards.
Future Outlook
The vesting schedules for the newly awarded stock options and Restricted Stock Units extend through February 2029 and February 2036, indicating a long-term incentive structure for the executive.
Industry Context
StockSavvy.ai notes that the grant of equity awards like stock options and Restricted Stock Units is a common practice in the insurance industry and broader corporate landscape to align executive incentives with long-term shareholder value. These awards typically vest over several years, encouraging executives to focus on sustained company performance.
Comparison to Industry Standards
- StockSavvy.ai observes that the structure of these equity awards, including multi-year vesting schedules and a mix of options and RSUs, is consistent with compensation practices seen at comparable large-cap insurance companies such as Progressive (PGR), Travelers (TRV), and Chubb (CB).
- The exercise price for options and the conversion of RSUs at no cost are standard for incentive-based compensation plans.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Executive Compensation Plan | Equity awards were granted under The Allstate Corporation 2019 Equity Incentive Plan, indicating adherence to an established corporate governance framework for executive compensation. | 02/19/2026 | Reinforces alignment of executive incentives with long-term shareholder interests through a pre-approved plan. |
Related Party Transactions
- The transactions involve an executive (Christine M. DeBiase) and the company (The Allstate Corporation), which are considered related parties. These are standard compensation awards under an approved equity incentive plan.
Stakeholder Impact
- Shareholders: The equity awards align the executive's interests with shareholder value creation over the long term.
- Employees: No direct impact on general employees is indicated.
- Customers, Suppliers, Creditors: No direct impact on these stakeholders is indicated.
Next Steps
- Employee stock options will vest in three increments on February 19, 2027, February 19, 2028, and February 19, 2029.
- 2,097 Restricted Stock Units will convert into common stock in three equal increments on February 19, 2027, February 19, 2028, and February 19, 2029.
- Remaining 905 Restricted Stock Units will convert into common shares on February 21, 2027.
Key Dates
| Date | Description |
|---|---|
| 02/19/2026 | Date of earliest transaction, grant of employee stock options and Restricted Stock Units. |
| 02/21/2026 | Conversion of previously awarded Restricted Stock Units into common shares and disposition of common shares. |
| 02/23/2026 | Date the Form 4 was signed. |
| 02/19/2027 | First vesting date for employee stock options and first conversion date for 2,097 RSUs. |
| 02/21/2027 | Conversion date for remaining 905 Restricted Stock Units. |
| 02/19/2028 | Second vesting date for employee stock options and second conversion date for 2,097 RSUs. |
| 02/19/2029 | Third vesting date for employee stock options and third conversion date for 2,097 RSUs. Also the expiration date for 2,097 RSUs. |
| 02/19/2036 | Expiration date for employee stock options. |
Recommendation
holdThis Form 4 filing details routine executive compensation awards and related transactions. It does not contain information that would fundamentally alter the investment thesis for Allstate. The awards align executive incentives with long-term performance, which is generally positive, but the filing itself is not a catalyst for a "buy" or "sell" decision. Therefore, a "hold" recommendation is appropriate as it reflects no new material information to change an existing position.
Keywords
Allstate Corporation, ALL, Christine M. DeBiase, Form 4, SEC filing, Insider transaction, Equity awards, Restricted Stock Units, Stock options, Executive compensation, Share ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.